Welcome to our new post! In this article, we will have a look at top stocks that can double money in less than 3 years.
Can making investments in stock market make you rich? If yes, what can be the potential strategies and in which stocks should you invest?
The first question is rarely asked anymore as time and again data has proved that making investments in the share market is one of the best ways to increase wealth in a certain time.
This was further supported by the report in October 2023 which talked about rise of “mini-millionaires.” The report was released by the Wall Street Journal. Report has also highlighted how average wealth of American families continues to increase. Per the report, mini-millionaires mint around $150,000 – $250,000 per year year. This report mentioned that, between 2019 and 2022, families in 80th – 90th percentile of income distribution saw strongest increase in incomes, with their wealth increasing by ~69% from 2019 through 2022, if adjusted for inflation.
Now, you’d ask that how investing in the market has helped them? Well, much to your surprise, more than 90% of such families were invested in stocks, either through direct route or indirect route.
That being said, investing in stock market comes with its own challenges. You can’t get rich through making investments in low-quality stocks and in random companies which have no value. Stock investing needs patience, wiser choices and adhering to traditional investing principles.
With this in mind, let us now have a look at top stocks that can double money in less than 3 years.
1. ChargePoint Holdings, Inc.
The company designs, develops, and markets networked EV charging system infrastructure along with cloud-based services which allow consumers to locate, reserve, and authenticate EV charging.
It has released results for 3Q of fiscal 2024 ended October 31, 2023, with revenues coming at $110.3 million, exhibiting a fall of 12% from $125.3 million in previous year’s similar quarter. The company reaffirms its expectations to achieve positive non-GAAP Adjusted EBITDA in 4Q of calendar year 2024. The company demonstrated how it empowered entire EV ecosystem, throughout hardware and software, and it has also fortified its balance sheet. Thus, it is well-capitalized to execute on its strategy.
Networked charging systems revenue for 3Q came in at $73.9 million, exhibiting a fall of 24% from $97.6 million in previous year’s same quarter. Subscription revenue came at $30.6 million, up by 41% from $21.7 million in previous year’s same quarter.
Non-GAAP adjusted EBITDA loss came at $97.4 million, which reflects inventory impairment charge in the 3Q in comparison to $51.5 million in previous year’s same quarter.
As at October 31, 2023, the company’s cash, cash equivalents and restricted cash on balance sheet came in at $397.4 million, that consists $233.1 million of at-the-market share offering gross proceeds during 3Q. The company’s $150 million revolving credit facility is undrawn and it has no debt maturities up until 2028. Its GAAP operating expense came at $130 million and non-GAAP operating expense was $81 million. This partially reflects reduction of operating expenses as part of cost-saving measures.
2. Tarsus Pharmaceuticals, Inc.
The company is a late clinical-stage biopharmaceutical company, focused on development and commercialization of first-in-class therapeutic candidates which can provide treatment for ophthalmic conditions.
The company has released financial results for 3Q ended September 30, 2023 with recent business achievements. On 24 July, XDEMVY® got approved by the US Food and Drug Administration (FDA) as the first and only therapeutic for Demodex blepharitis (DB). This is a highly prevalent eyelid disease impacting ~25 million eye care patients in the US.
In 3Q23, the company’s XDEMVY generated $1.7 million in net product sales, with ~1,700 bottles of XDEMVY being delivered to patients. Contract discussions with critical commercial and medicare accounts are still underway.
Total revenues of the company came in at $1.9 million, which was mainly because of $1.7 million in net product sales. It represents 5 weeks of sales after launch of XDEMVY in late August. R&D expenses came in at $12.1 million for 3Q23 against $10.9 million for same period in 2022.
This rise was because of $2.8 million of payroll expense (which includes non-cash stock-based compensation). It got partially offset by $1.9 million of program spend for TP-03. Net loss for 3Q23 came at $39.1 million against net loss of $22.5 million for same period in 2022.
3. The AES Corporation
The AES Corporation is a global power company. It has released its 3Q23 financial highlights. The company’s 3Q23 diluted EPS came in at $0.32 as compared to $0.59 in 3Q22. Its 3Q23 adjusted EPS was $0.60 against $0.63 in 3Q22.
With YTD adjusted EPS of $1.03, the company expects full-year adjusted EPS to be in top half of guidance range of between $1.65 – $1.75.
The company had a strong 3Q across the board and it is on track to deliver on all of the financial and strategic objectives. Demand for renewables having long-term contracts is strong throughout the sector, and particularly from the primary customers, large technology companies along with data centers.
3Q23 net income came in at $291 million, exhibiting a fall of $155 million in comparison to 3Q22. This fall was due to lower contributions from LNG transactions against 2022 at Energy Infrastructure Strategic Business Unit (SBU), which was partially offset by favorable contributions at the utilities, renewables, and new energy technologies SBUs.
Conclusion
While above are some of the top stocks that can double money in less than 3 years, there are several other stocks which have the same potential.
But should you invest keeping in mind that your money will get doubled by investing in top stocks? Well, certainly not! Even though there are stocks holding potential, the equity market as a general is significantly volatile.
Each and every individual has a unique financial situation. Therefore, the best way for making investment depends on the personal preferences and an investor’s current and future circumstances.
Read Also: